Advances in EGFR/HER2-directed clinical research on breast cancer.
Adv Cancer Res
; 147: 375-428, 2020.
Article
in En
| MEDLINE
| ID: mdl-32593406
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
/
Protein Kinase Inhibitors
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Adv Cancer Res
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos